Connection

Whitney Graybill to Molecular Targeted Therapy

This is a "connection" page, showing publications Whitney Graybill has written about Molecular Targeted Therapy.
Connection Strength

0.106
  1. Vintafolide: a novel targeted agent for epithelial ovarian cancer. Future Oncol. 2014 Mar; 10(4):541-8.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.